Your browser doesn't support javascript.
loading
Rationale and design of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial: a randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.
Desai, Akshay S; Lewis, Eldrin F; Li, Rebecca; Solomon, Scott D; Assmann, Susan F; Boineau, Robin; Clausell, Nadine; Diaz, Rafael; Fleg, Jerome L; Gordeev, Ivan; McKinlay, Sonja; O'Meara, Eileen; Shaburishvili, Tamaz; Pitt, Bertram; Pfeffer, Marc A.
Affiliation
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA 02115, USA. adesai@partners.org
Am Heart J ; 162(6): 966-972.e10, 2011 Dec.
Article in En | MEDLINE | ID: mdl-22137068
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Spironolactone / Mineralocorticoid Receptor Antagonists / Heart Failure Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2011 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Research Design / Spironolactone / Mineralocorticoid Receptor Antagonists / Heart Failure Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Female / Humans / Male / Middle aged Language: En Journal: Am Heart J Year: 2011 Document type: Article Affiliation country: United States